Jul 19, 2014 at 16:08 | Source: Moneycontrol.com
Last week the Bombay High Court upheld the compulsory license granted to Indian pharma company Natco for the sale of a generic version of Bayer's anti-cancer drug Nexavar. Here's a look back at the first legal challenge against a compulsory license in India.
Jul 16, 2014 at 09:01 | Source: Moneycontrol.com
Natco is pleased to inform that the Bombay High Court upheld the compulsory license (CL) granted to the Company on Nexavar (sorafenib tosylate) of German drug Major Bayers patented kidney cancer drug.
Jul 14, 2014 at 12:12 | Source: CNBC-TV18
According to Kewal Handa, the pricing regulator (NPPA) has fixed prices of medicines that are not included in the national list of essential medicines (NLEM) and may also add more drugs, especially the cancer drugs going ahead.
Jul 03, 2014 at 17:26 | Source: Reuters
The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in Gujarat, the FDA said in a post on its website.
May 15, 2014 at 11:49 | Source: Moneycontrol.com
Sun Pharma is allowed to launch a generic version of Novartis ' leukemia drug Gleevec in the United States on February 1, 2016, under a settlement agreement between the two companies.
May 15, 2014 at 10:59 | Source: Reuters
Pascal Soriot, Chief Executive said that if the offer reflected the value of the company as well as addressed some of the integration aspects, operating model and execution risks that we are concerned about, we shall certainly engage.
Apr 22, 2014 at 18:34 | Source: PTI
As part of the three-way transaction announced today, the Swiss firm will buy GSK's cancer drugs portfolio for USD 16 billion and sell its vaccines business in return for USD 7.1 billion.
Mar 11, 2014 at 19:10 | Source: CNBC-TV18
Compulsory licence is a tool through which developing countries like India can produce patented drugs, can allow companies to produce patented drugs in a much cheaper and affordable way.
Mar 07, 2014 at 15:27 | Source: CNBC-TV18
Biocon CMD Kiran Mazumdar-Shaw said the companys research efforts are focused on a number of programs that deliver drugs that women can benefit from.
Mar 06, 2014 at 19:45 | Source: Reuters
An Indian committee is reviewing up to a dozen patented drugs to see if so-called compulsory licences, which in effect break exclusivity rights, can be issued for some of them, two senior government officials said last month.